Summer 2019 Issue
Welcome to the inaugural issue of the Stanford Center for Clinical Research (SCCR) newsletter.
Since SCCR was founded more than four years ago, we have grown into a group of over 70 research staff, partnered with more than 50 faculty on campus, and conducted or currently run in excess of 125 research projects.
Each issue will highlight our many collaborations and work with other universities, government agencies, philanthropic partners, and industry – including tech, digital health, biopharma, and biotech companies.
You will also read about SCCR’s media coverage, education and training events, initiatives, publications, conferences, staff, and faculty partners.
I am incredibly proud of the great science that is being done in SCCR, as well as the commitment of our staff to innovation, quality, and collaboration. I am thankful to the many faculty, house staff and researchers, and to our industry and government partners, with whom we have been able to work.
For more information, or to partner with us, please send a message to email@example.com.
Thanks for reading.
Kenneth W. Mahaffey, MD
In This Issue
SCCR welcomes Nadia Elkarra, MD, who recently joined as the associate director of the Coordinating Center. In her new role, she will lead a highly skilled team that provides a full array of clinical research services for trials supported by industry, foundations and government sponsors.
SCCR is leading the research operations for Taube Stanford Children's Concussion Initiative, an innovative effort to look at how mouthguards may protect adolescent and young adult athletes from brain injury.
A recent SCCR program told health care professionals about prescription drug misuse and how they can assist with recovering from the national opioid epidemic. Read about that and another program, in conjunction with the American College of Cardiology.
Read how Christoph Olivier, MD, is building lasting relationships between Heart Center Freiburg University and Stanford following his two-and-a-half-year SCCR fellowship.
Recent successes in the field of Hepatitis C research have prompted efforts to find effective treatments for a variety of liver diseases including Hepatitis B and non-alcoholic fatty liver disease among other chronic liver diseases.
Media reports have addressed SCCR’s recent activities, including a study on using wearable technology to identify cardiac problems, a major effort to understand the underpinnings of health and disease, and how SCCR helps drive research.
SCCR’s Quality and Compliance team calls attention to a document recently issued by the FDA: draft guidance on risk-based monitoring. Through a series of questions and answers, the document is intended to assist research sponsors with the development of RBM plans.